Turn your vision into a compelling investment case. Raising capital is no longer about having a great product — it's about telling a powerful story backed by numbers, traction, and a clear plan.
We help companies prepare for fundraising or strategic transactions through structured analysis, storytelling, and capital strategy design. Whether you're a seed-stage founder or a Series B company preparing for institutional due diligence, we bring the rigour and investor perspective that serious capital conversations require.
A refined storyline that articulates market opportunity, technology differentiation, traction, moat, and upside — structured the way institutional investors actually read decks.
Institutional-grade financial models with sensitivity analyses, comparable benchmarking, and scenario planning that withstands serious investor scrutiny.
Mapping of angels, VCs, corporate investors, family offices, and non-dilutive opportunities — matched to your stage, sector, and target geography.
End-to-end data room preparation ensuring your company stands up to institutional scrutiny — legal, financial, technical, and commercial.
Practical, direct guidance to help founders communicate with clarity and conviction. Mock sessions, objection handling, and narrative sharpening.
Grant strategy (NSF, EIC, Innovate UK, BIRAC, NIHR, DARPA/DIU), pre-deal commercial strategy review, and board & governance advisory.
Companies preparing for a raise at any institutional stage, from first-time founders to experienced operators.
Founders in biotech, medtech, AI, and frontier tech where the technology story is complex and the investor audience is sophisticated.
Teams preparing for acquisition conversations, strategic partnerships, or corporate investment rounds.
University and lab spinouts transitioning from research excellence into investable, commercially structured ventures.